MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00520-026-11338-x

Медицинская библиотека · Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026

Comorbidity patterns and their associations with performance status and treatment receipt in breast and colorectal cancers in a multiethnic Asian setting: a latent class analysis.

Hoo Yee-Yin, Ng Huah Shin, Danaee Mahmoud, Koczwara Bogda, Ramalingam Sivatharshini, Subramaniam Shridevi, Abdul Satar Nur Fadhlina, Thiagarajan Muthukkumaran, Yip Cheng Har, Bhoo-Pathy Nirmala

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: Comorbidity is usually summarised as a count or index, which treats different combinations of conditions equally. Whether distinct comorbidity patterns have different implications for management decisions in cancer is unclear. We applied latent class analysis (LCA) to identify comorbidity patterns and examined their associations with performance status and cancer treatment in individuals with breast or colorectal cancer.

METHODS

Data from two Malaysian cohorts comprising adults with breast or colorectal cancer were analysed. Comorbidities, verified against medical records, were grouped into 20 categories. LCA was used to identify comorbidity patterns. Outcomes included ECOG performance status (0-1 vs ≥ 2) and receipt of treatment (surgery, chemotherapy, radiotherapy, immunotherapy, anti-HER2, CDK4/6 inhibitors, hormone therapy).

RESULTS

Among 1117 individuals, 695 (62.2%) had ≥ 1 comorbidity. Hypertension, dyslipidaemia, diabetes and obesity were most prevalent. LCA identified three classes: low (n = 723), cardiovascular-kidney-metabolic (CKM) (n = 368) and multisystem (n = 26). All in the multisystem group and half in the CKM group had modified Charlson Comorbidity Index ≥ 3. The CKM group was older than the low-comorbidity group (62 vs 51 years) but did not differ in performance or treatment status. The multisystem group however had poorer performance status (adjusted odds ratio [aOR] = 4.04, 95%CI = 1.50-10.84), lower odds of receiving chemotherapy (aOR = 0.10, 95%CI = 0.04-0.25) and anti-HER2 therapy (aOR = 0.14, 95%CI = 0.02-0.86).

CONCLUSION

Comorbidity patterns revealed differences that counts alone would have missed. The CKM class had similar performance status and treatment receipt to the low-comorbidity class despite cardiovascular and renal comorbidity, highlighting risks not reflected by performance status. The multisystem class requires validation.

Для цитирования: Hoo Yee-Yin, Ng Huah Shin, Danaee Mahmoud, Koczwara Bogda, Ramalingam Sivatharshini, Subramaniam Shridevi, Abdul Satar Nur Fadhlina, Thiagarajan Muthukkumaran, Yip Cheng Har, Bhoo-Pathy Nirmala. Comorbidity patterns and their associations with performance status and treatment receipt in breast and colorectal cancers in a multiethnic Asian setting: a latent class analysis.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2026. DOI: 10.1007/s00520-026-11338-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.